Why CMS is prioritizing value-based care and how healthcare companies can support this initiative
The road to value-based care is evolving as technology advances. An important tool for this journey is artificial intelligence and machine learning.
Category: Center for Medicare and Medicaid Services
The road to value-based care is evolving as technology advances. An important tool for this journey is artificial intelligence and machine learning.
A CMS rule, which went into effect December 31, requires that providers publish up-to-date digital contact information regarding their compliance, using approved methods. Noncompliant hospitals will be publicly listed, akin to the Office of Civil Rights’ breach notification portal, the so-called “Wall of Shame.”
Six years in, the subtext of the scheduled reimbursements increase for 2022 is that CCM has proven to be an essential part of the care continuum, particularly in the wake of the Covid-19 pandemic, and has real value for patients, providers, and payers.
The Center for Medicare and Medicaid Services proposes covering Biogen Alzheimer’s disease drug Aduhelm only for people enrolled in a clinical trial. In explaining this proposal, the agency cited the unclear benefit to patients as well as the documented safety risks associated with the drug, which can be best monitored within the context of a […]
The price of Biogen Alzheimer’s disease drug Aduhelm will be cut in half at the start of 2022, a move that comes as a Medicare recommendation on coverage is expected early next year. Meanwhile, Biogen is preparing corporate measures projected to save $500 million annually, cost-cutting made necessary in part due to slow market uptake […]